Portfolio company Setpoint Medical presented late-breaking 24-week RESET-RA study data at ACR Convergence 2024.
Setpoint Medical is a clinical-stage healthcare company dedicated to treating chronic autoimmune diseases through innovative therapies, including a novel neuroimmune modulation platform designed to stimulate the vagus nerve to reduce inflammation and restore immune balance
Setpoint Medical is a clinical-stage healthcare company dedicated to treating chronic autoimmune diseases through innovative therapies, including a novel neuroimmune modulation platform designed to stimulate the vagus nerve to reduce inflammation and restore immune balance.